IFRX Valuation
InflaRx NV
$
0.833
- Overview
- Forecast
- Valuation
- Earnings
IFRX Relative Valuation
IFRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IFRX is overvalued; if below, it's undervalued.
Historical Valuation
InflaRx NV (IFRX) is now in the Fair zone, suggesting that its current forward PS ratio of 271.34 is considered Fairly compared with the five-year average of -2.51. The fair price of InflaRx NV (IFRX) is between 0.57 to 1.96 according to relative valuation methord.
Relative Value
Fair Zone
0.57-1.96
Current Price：0.82
Fair
-1.43
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
InflaRx NV. (IFRX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.13. The thresholds are as follows: Strongly Undervalued below -7.32, Undervalued between -7.32 and -4.23, Fairly Valued between 1.96 and -4.23, Overvalued between 1.96 and 5.06, and Strongly Overvalued above 5.06. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.00
EV/EBIT
InflaRx NV. (IFRX) has a current EV/EBIT of -0.00. The 5-year average EV/EBIT is -1.07. The thresholds are as follows: Strongly Undervalued below -3.56, Undervalued between -3.56 and -2.32, Fairly Valued between 0.18 and -2.32, Overvalued between 0.18 and 1.43, and Strongly Overvalued above 1.43. The current Forward EV/EBIT of -0.00 falls within the Historic Trend Line -Fairly Valued range.
280.01
PS
InflaRx NV. (IFRX) has a current PS of 280.01. The 5-year average PS is 1837.66. The thresholds are as follows: Strongly Undervalued below -12448.57, Undervalued between -12448.57 and -5305.46, Fairly Valued between 8980.77 and -5305.46, Overvalued between 8980.77 and 16123.88, and Strongly Overvalued above 16123.88. The current Forward PS of 280.01 falls within the Historic Trend Line -Fairly Valued range.
-1.07
P/OCF
InflaRx NV. (IFRX) has a current P/OCF of -1.07. The 5-year average P/OCF is -2.39. The thresholds are as follows: Strongly Undervalued below -4.67, Undervalued between -4.67 and -3.53, Fairly Valued between -1.26 and -3.53, Overvalued between -1.26 and -0.12, and Strongly Overvalued above -0.12. The current Forward P/OCF of -1.07 falls within the Overvalued range.
-1.00
P/FCF
InflaRx NV. (IFRX) has a current P/FCF of -1.00. The 5-year average P/FCF is -3.06. The thresholds are as follows: Strongly Undervalued below -9.30, Undervalued between -9.30 and -6.18, Fairly Valued between 0.06 and -6.18, Overvalued between 0.06 and 3.18, and Strongly Overvalued above 3.18. The current Forward P/FCF of -1.00 falls within the Historic Trend Line -Fairly Valued range.
InflaRx NV (IFRX) has a current Price-to-Book (P/B) ratio of 0.84. Compared to its 3-year average P/B ratio of 1.23 , the current P/B ratio is approximately -31.86% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about -27.97% higher. InflaRx NV (IFRX) has a Forward Free Cash Flow (FCF) yield of approximately -92.71%. Compared to its 3-year average FCF yield of -43.17%, the current FCF yield is approximately 114.76% lower. Relative to its 5-year average FCF yield of -41.73% , the current FCF yield is about 122.15% lower.
0.83
P/B
Median3y
1.23
Median5y
1.17
-89.84
FCF Yield
Median3y
-43.17
Median5y
-41.73
Competitors Valuation Multiple
The average P/S ratio for IFRX's competitors is 7.87, providing a benchmark for relative valuation. InflaRx NV Corp (IFRX) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 520.29%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IFRX decreased by 46.60% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 6.36K to 39.43K.
The secondary factor is the Margin Expansion, contributed -83.21%to the performance.
Overall, the performance of IFRX in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
NIU
NIU Technologies
4.300
USD
+11.69%
FTLF
FitLife Brands Inc
16.780
USD
+7.36%
AMWL
American Well Corp
7.060
USD
-1.53%
ADAP
Adaptimmune Therapeutics PLC
0.077
USD
-10.49%
RCMT
R C M Technologies Inc
24.120
USD
+5.24%
BOOM
DMC Global Inc
6.160
USD
+0.98%
HFFG
Hf Foods Group Inc
3.330
USD
+9.18%
GPMT
Granite Point Mortgage Trust Inc
2.760
USD
+0.36%
FRAF
Franklin Financial Services Corp
42.820
USD
+6.94%
FAQ
Is InflaRx NV (IFRX) currently overvalued or undervalued?
InflaRx NV (IFRX) is now in the Fair zone, suggesting that its current forward PS ratio of 271.34 is considered Fairly compared with the five-year average of -2.51. The fair price of InflaRx NV (IFRX) is between 0.57 to 1.96 according to relative valuation methord.
What is InflaRx NV (IFRX) fair value?
How does IFRX's valuation metrics compare to the industry average?
What is the current P/B ratio for InflaRx NV (IFRX) as of Aug 13 2025?
What is the current FCF Yield for InflaRx NV (IFRX) as of Aug 13 2025?
What is the current Forward P/E ratio for InflaRx NV (IFRX) as of Aug 13 2025?